Suppr超能文献

对淋巴瘤多步骤转化过程的见解:克隆相关的复合霍奇金淋巴瘤和非霍奇金淋巴瘤中的IgH相关易位及肿瘤抑制基因突变

Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas.

作者信息

Schmitz R, Renné C, Rosenquist R, Tinguely M, Distler V, Menestrina F, Lestani M, Stankovic T, Austen B, Bräuninger A, Hansmann M-L, Küppers R

机构信息

Institute for Cell Biology (Tumor Research), University of Duisburg-Essen Medical School, Essen, Germany.

出版信息

Leukemia. 2005 Aug;19(8):1452-8. doi: 10.1038/sj.leu.2403841.

Abstract

Clonally related composite lymphomas of Hodgkin's lymphoma (HL) and Non-Hodgkin's lymphoma (NHL) represent models to study the multistep transformation process in tumorigenesis and the development of two distinct tumors from a shared precursor. We analyzed six such lymphomas for transforming events. The HLs were combined in two cases with follicular lymphoma (FL), and in one case each with B-cell chronic lymphocytic leukemia, splenic marginal zone lymphoma, mantle cell lymphoma (MCL) and diffuse large B-cell lymphoma (DLBCL). In the HL/FL and HL/MCL combinations, BCL2/IGH and CCND1/IGH translocations, respectively, were detected in both the HL and NHL. No mutations were found in the tumor suppressor genes FAS, NFKBIA and ATM. The HL/DLBCL case harbored clonal replacement mutations of the TP53 gene on both alleles exclusively in the DLBCL. In conclusion, we present the first examples of molecularly verified IgH-associated translocations in HL, which also show that BCL2/IGH or CCND1/IGH translocations can represent early steps in the pathogenesis of composite HL/FL or HL/MCL. The restriction of the TP53 mutations to the DLBCL in the HL/DLBCL case exemplifies a late transforming event that presumably happened in the germinal center and affected the fate of a common lymphoma precursor cell towards development of a DLBCL.

摘要

霍奇金淋巴瘤(HL)和非霍奇金淋巴瘤(NHL)的克隆相关复合淋巴瘤代表了研究肿瘤发生过程中多步骤转化过程以及由共同前体发展出两种不同肿瘤的模型。我们分析了6例此类淋巴瘤的转化事件。其中2例HL与滤泡性淋巴瘤(FL)合并,另1例HL分别与B细胞慢性淋巴细胞白血病、脾边缘区淋巴瘤、套细胞淋巴瘤(MCL)和弥漫性大B细胞淋巴瘤(DLBCL)合并。在HL/FL和HL/MCL组合中,HL和NHL均检测到BCL2/IGH和CCND1/IGH易位。在肿瘤抑制基因FAS、NFKBIA和ATM中未发现突变。HL/DLBCL病例仅在DLBCL中两个等位基因上均存在TP53基因的克隆性替代突变。总之,我们展示了HL中分子验证的IgH相关易位的首个实例,这也表明BCL2/IGH或CCND1/IGH易位可能代表复合HL/FL或HL/MCL发病机制的早期步骤。HL/DLBCL病例中TP53突变局限于DLBCL,这是一个晚期转化事件的例证,推测该事件发生在生发中心,并影响了共同淋巴瘤前体细胞向DLBCL发展的命运。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验